Todd D. Bosse

Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model

Dale J. Kempf, William E. Kohlbrenner, Rolf Wagner, 2007, Antimicrobial Agents and Chemotherapy.

Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives.

V. Stoll, A. Molla, D. Kempf, 2008, Bioorganic & medicinal chemistry letters.

Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines.

A. C. Krueger, A. Molla, D. Kempf, 2009, Journal of medicinal chemistry.

Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.

H. Mo, T. Pilot‐Matias, K. Stewart, 2007, Antiviral research.

Halophilic reactions of a stable silylene with chloro and bromocarbons.

R. West, I. Guzei, J. Olson, 2002, Journal of the American Chemical Society.

Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors.

A. Molla, D. Kempf, H. Mo, 2008, Bioorganic & medicinal chemistry letters.